Diatriazoate
Brand names,
Diatriazoate
Analogs
Diatriazoate
Brand Names Mixture
Diatriazoate
Chemical_Formula
C9H15N5O3
Diatriazoate
RX_link
No information avaliable
Diatriazoate
fda sheet
Diatriazoate
msds (material safety sheet)
Diatriazoate
Synthesis Reference
No information avaliable
Diatriazoate
Molecular Weight
241.247 g/mol
Diatriazoate
Melting Point
250-255 oC (hydrochloride salt)
Diatriazoate
H2O Solubility
>20 mg/mL (dichloride salt)
Diatriazoate
State
Solid
Diatriazoate
LogP
-1.783
Diatriazoate
Dosage Forms
No information avaliable
Diatriazoate
Indication
For the treatment of tetrahydrobiopterin (BH4) deficiency.
Diatriazoate
Pharmacology
Tetrahydrobiopterin (BH4) is used to convert several amino acids, including phenylalanine, to other essential molecules in the body including neurotransmitters. Tetrahydrobiopterin deficiency can be caused by mutations in GTP cyclohydrolase 1 (GCH1), 6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (PCBD1), 6-pyruvoyltetrahydropterin synthase (PTS), and quinoid dihydropteridine reductase (QDPR) genes. These genes make the enzymes that are critical for producing and recycling tetrahydrobiopterin. If one of the enzymes fails to function correctly because of a gene mutation, little or no tetrahydrobiopterin is produced. As a result, phenylalanine from the diet builds up in the bloodstream and other tissues and can damage nerve cells in the brain. High levels of phenylalanine can result in signs and symptoms ranging from temporary low muscle tone to mental retardation, movement disorders, difficulty swallowing, seizures, behavioral problems, progressive problems with development, and an inability to control body temperature.
Diatriazoate
Absorption
No information avaliable
Diatriazoate
side effects and Toxicity
No information avaliable
Diatriazoate
Patient Information
No information avaliable
Diatriazoate
Organisms Affected
Humans and other mammals